Literature DB >> 15667195

Surface fabrication of hollow microspheres from N-methylated chitosan cross-linked with glutaraldehyde.

Xianghong Peng1, Lina Zhang.   

Abstract

We have successfully prepared biocompatible and biodegradable hollow microspheres with sizes between 2 and 5 mum using cyclohexane droplets as a template and the N-methylated chitosan (NMC) cross-linked with glutaraldehyde (GA) as the shell. The structure, morphology, and formation process of the hollow microspheres were characterized by FT-IR, (1)H and (13)C NMR, scanning electron microscopy (SEM), and transmission electron microscopy (TEM). The results revealed that the microspheres exhibited a very smooth and hollow structure. This work confirmed that the hollow microspheres were accomplished by fabricating on the basis of chemical cross-linking on the surface of the emulsion droplets and by removing cyclohexane as core. The results from SEM and TEM indicated that the emulsion droplets covered with cross-linked NMC in the oil-in-water system aggregated together to form a precipitate of microspheres by coagulating with acetone. Moreover, the cross-linked NMC on the surface of the microspheres continuously cured to form the tight shell, whereas the inner area became a cavity with increase of the aging time, leading to the hollow microspheres. In addition, an anti-infective drug, ofloxacin (Floxin), encapsulated in the microspheres more rapidly released to reach 90 wt % at pH 7.4 within 8 h than at pH 1.2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15667195     DOI: 10.1021/la047689w

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  2 in total

Review 1.  Trimethyl chitosan and its applications in drug delivery.

Authors:  V K Mourya; Nazma N Inamdar
Journal:  J Mater Sci Mater Med       Date:  2008-12-27       Impact factor: 3.896

2.  Camptothecin nanocolloids based on N,N,N-trimethyl chitosan: efficient suppression of growth of multiple myeloma in a murine model.

Authors:  Zhengguang Li; Xingyi Li; Zhixing Cao; Youzhi Xu; Hongjun Lin; Yinglan Zhao; Yuquan Wei; Zhiyong Qian
Journal:  Oncol Rep       Date:  2012-01-12       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.